Genetic Technologies Limited (GTG) Acting CEO George Muchnicki on Quarterly Investor Webinar Transcript
Ending wrap:
"And it's a bit like everyone's making cars, but we've made a car that's like an electric car or it's got that superpower to do, and not just more but much, much, much, much more. In other words, we've gone from 5% of breast cancer – 5% to 10% with the current best practices of germline to, let's say, 99% in case I'm wrong, but this is a – it's a tremendous increase in your ability to be meaningful. It's not just incremental by 5% or 10%. So, the danger for us is when we go to the clinicians. And trust me, there's a lot of clinicians they got no idea about this and we have to introduce it without them falling off their chair and we want to say to them, this is many times better than anything that you've seen before, and we have to say it in a way that doesn't sound too good to be true."
-----------
The market cap is low for this stock, they have real products with an increasing interest.. .
I have been waiting for them to include the BRACA test component & they have, The market needs to realise this!
plus 18 months cash in reserve.
GLAH.
.
Add to My Watchlist
What is My Watchlist?